These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 38288807)

  • 1. Tackling Nontuberculous Mycobacteria by Repurposable Drugs and Potential Leads from Natural Products.
    Adhikrao PA; Motiram GM; Kumar G
    Curr Top Med Chem; 2024; 24(15):1291-1326. PubMed ID: 38288807
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Zhu R; Shang Y; Chen S; Xiao H; Ren R; Wang F; Xue Y; Li L; Li Y; Chu N; Huang H
    Microbiol Spectr; 2022 Dec; 10(6):e0137222. PubMed ID: 36250885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activities of Dual Combinations of Antibiotics Against Multidrug-Resistant Nontuberculous Mycobacteria Recovered from Patients with Cystic Fibrosis.
    Schwartz M; Fisher S; Story-Roller E; Lamichhane G; Parrish N
    Microb Drug Resist; 2018 Oct; 24(8):1191-1197. PubMed ID: 29368988
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Kim DH; Jhun BW; Moon SM; Kim SY; Jeon K; Kwon OJ; Huh HJ; Lee NY; Shin SJ; Daley CL; Koh WJ
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria.
    van Ingen J; Boeree MJ; van Soolingen D; Mouton JW
    Drug Resist Updat; 2012 Jun; 15(3):149-61. PubMed ID: 22525524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Non-Tuberculosis Mycobacteria by Line Probe Assay and Determination of Drug Resistance Patterns of Isolates in Iranian Patients.
    Karami-Zarandi M; Bahador A; Gizaw Feysia S; Kardan-Yamchi J; Hasan-Nejad M; Mosavari N; Feizabadi MM
    Arch Razi Inst; 2019 Dec; 74(4):375-384. PubMed ID: 31939254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medications and monitoring in nontuberculous mycobacteria infections.
    Egelund EF; Fennelly KP; Peloquin CA
    Clin Chest Med; 2015 Mar; 36(1):55-66. PubMed ID: 25676519
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Sun Q; Liao X; Wang C; Jiang G; Yang J; Zhao J; Huang H; Wang G; Li H
    J Med Microbiol; 2022 Jun; 71(6):. PubMed ID: 35708979
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug susceptibility profiles and factors associated with non-tuberculous mycobacteria species circulating among patients diagnosed with pulmonary tuberculosis in Tanzania.
    Maya TG; Komba EV; Mensah GI; Mbelele PM; Mpagama SG; Mfinanga SG; Addo KK; Kazwala RR
    PLoS One; 2022; 17(3):e0265358. PubMed ID: 35324922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Managing antibiotic resistance in nontuberculous mycobacterial pulmonary disease: challenges and new approaches.
    Kwon YS; Daley CL; Koh WJ
    Expert Rev Respir Med; 2019 Sep; 13(9):851-861. PubMed ID: 31256694
    [No Abstract]   [Full Text] [Related]  

  • 11. Sudapyridine (WX-081) antibacterial activity against
    Zheng L; Wang H; Qi X; Zhang W; Wang B; Fu L; Chen X; Chen X; Lu Y
    mSphere; 2024 Feb; 9(2):e0051823. PubMed ID: 38240581
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Luo J; Yu X; Jiang G; Fu Y; Huo F; Ma Y; Wang F; Shang Y; Liang Q; Xue Y; Huang H
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29760127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial susceptibility and MIC distribution of 41 drugs against clinical isolates from China and reference strains of nontuberculous mycobacteria.
    Li G; Pang H; Guo Q; Huang M; Tan Y; Li C; Wei J; Xia Y; Jiang Y; Zhao X; Liu H; Zhao LL; Liu Z; Xu D; Wan K
    Int J Antimicrob Agents; 2017 Mar; 49(3):364-374. PubMed ID: 28131606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efflux Pump Inhibitors Against Nontuberculous Mycobacteria.
    Rindi L
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32545436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specificity of Immunoglobulin Response to Nontuberculous Mycobacteria Infection in People with Cystic Fibrosis.
    Malcolm KC; Wheeler EA; Calhoun K; Lenhart-Pendergrass PM; Rysavy N; Poch KR; Caceres SM; Saavedra MT; Nick JA
    Microbiol Spectr; 2022 Aug; 10(4):e0187422. PubMed ID: 35863022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Distribution and drug resistance of nontuberculous
    Zhang J; Su JR; Ding BC; Liu JW; Yi JL; Yang XY; Wang NH; Wang SM
    Zhonghua Jie He He Hu Xi Za Zhi; 2017 Mar; 40(3):210-214. PubMed ID: 28297817
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of the new GenoType NTM-DR kit for the molecular detection of antimicrobial resistance in non-tuberculous mycobacteria.
    Mougari F; Loiseau J; Veziris N; Bernard C; Bercot B; Sougakoff W; Jarlier V; Raskine L; Cambau E;
    J Antimicrob Chemother; 2017 Jun; 72(6):1669-1677. PubMed ID: 28333340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-Tuberculous Mycobacteria: Classification, Diagnostics, and Therapy.
    Porvaznik I; Solovič I; Mokrý J
    Adv Exp Med Biol; 2017; 944():19-25. PubMed ID: 27826888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of current and promising nontuberculous mycobacteria antibiotics.
    Cantelli CR; Dassonville-Klimpt A; Sonnet P
    Future Med Chem; 2021 Aug; 13(16):1367-1395. PubMed ID: 34165325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of antimicrobial resistance in rare mycobacteria from a nosocomial environment.
    Pereira SG; Alarico S; Tiago I; Reis D; Nunes-Costa D; Cardoso O; Maranha A; Empadinhas N
    BMC Microbiol; 2019 Mar; 19(1):62. PubMed ID: 30890149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.